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344a Monday, February 17, 2014the evolution of disease, which mirrors the route of progression from ‘compen-
sated’ to ‘decompensated’ phenotypes that is part of the wider picture of heart
failure that encompasses changes to tissue structure and organelle morphology.
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This study focuses on a novel rescue mouse model generated to test the ef-
fect of regulatory light chain (RLC) phosphorylation on a diseased cardiac
phenotype. Pseudo-phosphorylation of the D166V (aspartic acid to valine)
mutation shown to be associated with a malignant phenotype of familial hy-
pertrophic cardiomyopathy (FHC) was examined. Transgenic (Tg) mice car-
rying the D166V mutation demonstrated severe functional and physiological
abnormalities and a significant decrease in endogenous RLC phosphorylation
compared with Tg-WT mice. These detrimental phenotypes were partially
rescued by either myosin light chain kinase-induced phosphorylation or by
using phosphomimic (S15D) D166V-RLC exchanged in porcine cardiac
muscle preparations. Transgenic rescue mice carrying the S15D-D166V mu-
tation have been generated and subjected to functional measurements.
Myofibrillar ATPase assays performed on Tg-S15D-D166V vs. Tg-D166V
and Tg-WT mice cardiac samples showed a pseudo-phosphorylation rescue
of an abnormal increase in calcium sensitivity (hallmark of FHC) caused by
the D166V mutation. A D166V-induced decrease in maximal ATPase activ-
ity was also reversed in Tg-S15D-D166V mice. Similarly, maximal force
and myofilament Ca2þ-sensitivity, that were largely compromised in Tg-
D166V skinned muscle fibers, were improved in the rescue mice and
brought to the level observed in Tg-WT. Histopathological analyses of heart
sections from age and gender matched mice from all groups demonstrated
an approximately four-fold decrease in the extent of fibrosis in the rescue
mice compared to Tg-D166V. The beneficial effects of S15D on the func-
tion of the D166V hearts were confirmed in vivo by invasive hemody-
namics. Results from this study emphasize the significance of RLC
phosphorylation in alleviating an FHC induced phenotype and could be
used in the development of therapeutic interventions to restore the normal
cardiac function.
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To understand the mechanism underlying the apical hypertrophic cardiomypa-
thy (AHCM)-causing mutation E99K in cardiac actin gene (ACTC), skinned
papillary muscle fibers from 2- and 5-mo old E99K transgenic mice were sub-
jected to sinusoidal length perturbations to study tension transients, and the
results were compared with those from age-matched non-transgenic (NTg)
mice.
We found that 1) at the standard activation, fibers from 5-mo E99K mice pro-
duced slightly lower tension, significantly lower stiffness, and significantly
lower rate constant of delayed tension (2pb), and lower magnitudes B and C
than those from 5-mo NTg mice; but these differences were not found in 2-
mo mice; 2) the basal stiffness at the relaxing state with or without BDM at
both 1 and 100Hz showed a trend of an increase in 2-mo and a trend of a
decrease in 5-mo E99K mice (without significance) compared to age-
matched NTg mice, and the tension and stiffness at rigor state were not signif-
icantly varied among different mouse groups; 3) pCa-tension study showed
increased pCa50 (Ca
2þ sensitivity) in 5-mo E99K mice, with a bigger change
in the 0 mM Pi solution (DpCa50=0.09, P=0.047) than in the 8 mM Pi solution
(DpCa50=0.04, P=0.091). A trend (not significant) of an increase in pCa50 was
also found in 2-mo E99K mice, and no difference with nH (cooperativity) in
both 2-mo and 5-mo mice.
We conclude that AHCM-causing ACTC E99K mutant resulted in alterations
in biomechanical parameters depending on age: there were no changes in the
observed parameters at 2 months, but more significant changes occurred at 5
months, which correlate well with the development of AHCM.1741-Pos Board B471
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Long-term exercise training is associated with characteristic structural and
functional changes of the myocardium, resulting in a condition called athlete’s
heart. Although exercise-induced left ventricular (LV) hypertrophy has been
investigated by several groups in animal models, a detailed hemodynamic char-
acterization is not available. We aimed at understanding the functional and
morphological changes in the heart following a three-month-long training
period in a rat model.
Athlete’s heart in rats was induced by swim training. The swimmer group was
exposed to 200 min/day exercise for 12 weeks. The control group swam only 5
min/day. Following the training period we assessed LV hypertrophy with echo-
cardiography and performed LV pressure-volume (P-V) analysis with a
pressure-conductance microcatheter to investigate in vivo cardiac function.
Finally, cardiac tissue histology was examined.
Echocardiography showed hypertrophy which was confirmed by LV wall-
thickness and heart weight data. Histology also verified LV hypertrophy.
We found unaltered heart rate, arterial pressure and LV end-diastolic volume
along with decreased LV end-systolic volume, thus increased stroke volume
and ejection fraction in the swimmers by invasive hemodynamic measure-
ments. The P-V-loop-derived sensitive, load-independent contractility in-
dexes, such as slope of end-systolic P-V relationship or preload recruitable
stroke work were significantly increased. The observed improvement of ven-
triculoarterial coupling along with increased LV stroke work and mechanical
efficiency reflect improved mechanoenergetics of athlete’s heart. Despite the
significant hypertrophy, we observed unaltered LV stiffness and improved
LV active relaxation.
According to our knowledge this is the first study that characterizes func-
tional changes and hemodynamic relations in exercise-induced cardiac hy-
pertrophy. Conceivably, changes in the active (myosin) and passive (titin)
sarcomeric elements underly the described functional myocardial
alterations.
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Alteration of the Ca2þ binding properties of the thin filament has been impli-
cated as the initiating factor for numerous cardiomyopathies. To directly test
if changes in the Ca2þ sensitivity of TnC can lead to altered heart function
and a diseased phenotype we utilized specifically engineered cardiac TnCs
with modified Ca sensitivities. The specifically designed TnCs allowed us
to test whether a direct increase (L48Q TnC) or decrease (D73N TnC) in
Ca2þ sensitivity of the myofilament would lead to a hypertrophic or dilated
cardiomyopathy, respectively. We used adeno-associated virus serotype 9
(AAV-9) containing either Control TnC, D73N TnC, or L48Q TnC to target
the heart. AAV-9 containing GFP or mCherry was used to verify that the
AAV-9 was able to infect the heart. The Ca2þ desensitized D73N TnC reca-
pitulated a dilated cardiomyopathy. The hearts presented with dilated ventri-
cles and had enlarged isolated cardiomyocytes that displayed decreased
contractility. In addition, nearly half of the D73N mice died suddenly by 8
weeks of age and demonstrated altered electrical properties via ECG - a com-
mon feature of human dilated cardiomyopathies. On the other hand, AAV-9
containing the Ca2þ sensitized L48Q TnC did not recapitulate the restrictive
or hypertrophic cardiomyopathy phenotypes commonly associated with
increased myofilament Ca2þ sensitivity. However, consistent with the
enhanced Ca2þ binding abilities of the L48Q TnC, the isolated L48Q TnC
cardiomyocytes showed increased contractility, which was recapitulated in
vivo via pressure-volume analysis. In summary, the results showed that an
alteration in the Ca2þ sensitivity of the myofilament can, but does not always,
lead to a diseased heart. In fact these engineered TnCs may be used as a
treatment strategy against various cardiac diseases such as myocardial
infarction.
